Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
Ecovyst, Inc. (ECVT)
NYSEMaterialsChemicals - SpecialtySnapshot 2026-11-04
$9.97-0.80%
Close 2026-11-04 · 1-day change
NYSEMaterialsChemicals - SpecialtySnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
0.87 → 0.87 EPS · FY ending Dec 31, 2027 · 3 analysts
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 3 to 3; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for ECVT yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Capital spending between $80M and $90M in FY26 | The company invests $80M-$90M in capital spending. | Broken | Capital spending falls below $80M or rises above $90M in FY26 | Capital expenditures: $30.668M FY2026-Q2; GAAP. Published target: $80M-$90M. Annual target cannot be compared with a quarterly or TTM observation. Aug 6, 202630,668,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 5, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
ECVT is a growth-oriented, acquisition-supported business with robust earnings quality, though it is currently loss-making. The multi-year view is intact and has recently shifted from mixed to mildly favorable, but management is rated neutral and recent financial performance is rated neutral.
The evidence describes ECVT as cheap versus peers, with a justified pricing tag and low fragility. The expectations gap is slightly negative, but the snapshot does not explain that measure in detail, so the market’s specific assumptions are unclear.
Near-term, revenue momentum has strengthened: second-quarter revenue rose 42% year over year, and management raised its 2026 sales guidance to $1.02 billion to $1.06 billion. The 2026 adjusted free cash flow target also increased at the low end, while capital expenditure guidance rose modestly; cash flow progress is mixed. Recent CFO and CEO transitions add uncertainty, and the near-term miss risk is described as low, with a caution about peer misses and ECVT’s smaller size.
A key near-term test is whether management sustains its raised guidance, since a reversal could hurt credibility. Over the multi-year view, execution on revenue growth and cash generation matters, while results and guidance from sector bellwethers LIN, ECL, and SHW could strengthen or weaken the Materials sector tailwind.
The 1-to-3-year thesis is intact, supported by rising sales guidance and a favorable sector backdrop, but ECVT remains loss-making and leadership changes leave execution to prove out. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| Free cash flow target is $40M-$55M. |
| Intact |
| Adjusted free cash flow falls below $40M in FY26 |
Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Revenue between $890M and $970M in FY26 | A primary condition in Ecovyst, Inc.'s published investment case. The stated target is ~$930M. | Intact | Revenue falls below $890M in FY26 | Revenue: $249.962M FY2026-Q2; GAAP. Published target: ~$930M. Annual target cannot be compared with a quarterly or TTM observation. Aug 6, 2026249,962,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$0.88 → $0.87 · observed estimates
$1.01B → $1.05B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $0.88 | $1,007,322,054 | 1 / 2 |
| 2026-07-25 | $0.88 | $1,075,809,520 | 3 / 3 |
| 2026-07-26 | $0.88 | $1,075,809,520 | 3 / 3 |
| 2026-07-27 | $0.88 | $1,075,809,520 | 3 / 3 |
| 2026-07-28 | $0.88 | $1,007,322,054 | 1 / 2 |
| 2026-07-29 | $0.88 | $1,007,322,054 | 1 / 2 |
| 2026-07-30 | $0.88 | $1,007,322,054 | 1 / 2 |
| 2026-07-31 | $0.88 | $1,075,809,520 | 3 / 3 |
| 2026-08-01 | $0.88 | $1,007,322,054 | 1 / 2 |
| 2026-08-02 | $0.88 | $1,075,809,520 | 3 / 3 |
| 2026-08-03 | $0.88 | $1,007,322,054 | 1 / 2 |
| 2026-08-04 | $0.88 | $1,007,322,054 | 1 / 2 |
| 2026-08-05 | $0.88 | $1,007,322,054 | 1 / 2 |
| 2026-08-06 | $0.88 | $1,075,809,520 | 3 / 3 |
| 2026-08-07 | $0.87 | $1,008,869,887 | 1 / 2 |
| 2026-08-08 | $0.88 | $1,066,036,890 | 5 / 5 |
| 2026-08-09 | $0.88 | $1,066,036,890 | 5 / 5 |
| 2026-08-10 | $0.88 | $1,066,036,890 | 5 / 5 |
| 2026-08-11 | $0.87 | $1,008,869,887 | 1 / 2 |
| 2026-08-12 | $0.88 | $1,066,036,890 | 5 / 5 |
| 2026-08-13 | $0.88 | $1,066,036,890 | 5 / 5 |
| 2026-08-14 | $0.87 | $1,008,869,887 | 1 / 2 |
| 2026-08-15 | $0.87 | $1,008,869,887 | 2 / 3 |
| 2026-08-16 | $0.87 | $1,008,869,887 | 2 / 3 |
| 2026-08-17 | $0.87 | $1,008,869,887 | 2 / 3 |
| 2026-08-18 | $0.87 | $1,008,869,887 | 2 / 3 |
| 2026-08-19 | $0.87 | $1,008,869,887 | 2 / 3 |
| 2026-08-20 | $0.88 | $1,019,036,887 | 3 / 4 |
| 2026-08-21 | $0.88 | $1,019,036,887 | 3 / 4 |
| 2026-08-22 | $0.88 | $1,019,036,887 | 3 / 4 |
| 2026-08-23 | $0.88 | $1,019,036,887 | 3 / 4 |
| 2026-08-24 | $0.88 | $1,019,036,887 | 3 / 4 |
| 2026-08-25 | $0.88 | $1,019,036,887 | 3 / 4 |
| 2026-08-26 | $0.88 | $1,019,036,887 | 3 / 4 |
| 2026-08-27 | $0.88 | $1,019,036,887 | 3 / 4 |
| 2026-08-28 | $0.88 | $1,019,036,887 | 3 / 4 |
| 2026-08-29 | $0.88 | $1,019,036,887 | 3 / 4 |
| 2026-08-30 | $0.88 | $1,019,036,887 | 3 / 4 |
| 2026-08-31 | $0.88 | $1,019,036,887 | 3 / 4 |
| 2026-09-01 | $0.88 | $1,019,036,887 | 3 / 4 |
| 2026-09-02 | $0.87 | $1,029,551,177 | 3 / 4 |
| 2026-09-03 | $0.87 | $1,029,551,177 | 3 / 4 |
| 2026-09-04 | $0.87 | $1,029,551,177 | 3 / 4 |
| 2026-09-05 | $0.87 | $1,029,551,177 | 3 / 4 |
| 2026-09-06 | $0.87 | $1,029,551,177 | 3 / 4 |
| 2026-09-07 | $0.87 | $1,029,551,177 | 3 / 4 |
| 2026-09-08 | $0.87 | $1,029,551,177 | 3 / 4 |
| 2026-09-09 | $0.87 | $1,029,551,177 | 3 / 4 |
| 2026-09-10 | $0.88 | $1,048,459,314 | 3 / 4 |
| 2026-09-11 | $0.88 | $1,048,459,314 | 3 / 4 |
| 2026-09-12 | $0.88 | $1,048,459,314 | 3 / 4 |
| 2026-09-13 | $0.88 | $1,048,459,314 | 3 / 4 |
| 2026-09-14 | $0.88 | $1,048,459,314 | 3 / 4 |
| 2026-09-15 | $0.88 | $1,048,459,314 | 3 / 4 |
| 2026-09-16 | $0.88 | $1,048,459,314 | 3 / 4 |
| 2026-09-17 | $0.87 | $1,054,292,647 | 3 / 4 |
| 2026-09-18 | $0.87 | $1,054,292,647 | 3 / 4 |
| 2026-09-19 | $0.87 | $1,054,292,647 | 3 / 4 |
| 2026-09-20 | $0.87 | $1,054,292,647 | 3 / 4 |
| 2026-09-21 | $0.87 | $1,054,292,647 | 3 / 4 |
| 2026-09-22 | $0.87 | $1,054,292,647 | 3 / 4 |
| 2026-09-23 | $0.87 | $1,054,292,647 | 3 / 4 |
| 2026-09-24 | $0.87 | $1,054,292,647 | 3 / 4 |
| 2026-09-25 | $0.87 | $1,054,292,647 | 3 / 4 |
| 2026-09-26 | $0.87 | $1,054,292,647 | 3 / 4 |
| 2026-09-27 | $0.87 | $1,054,292,647 | 3 / 4 |
| 2026-09-28 | $0.87 | $1,054,292,647 | 3 / 4 |
| 2026-09-29 | $0.87 | $1,054,292,647 | 3 / 4 |
| 2026-09-30 | $0.87 | $1,054,292,647 | 3 / 4 |
| 2026-10-01 | $0.87 | $1,054,292,647 | 3 / 4 |
| 2026-10-02 | $0.87 | $1,054,292,647 | 3 / 4 |
| 2026-10-03 | $0.87 | $1,054,292,647 | 3 / 4 |
| 2026-10-04 | $0.87 | $1,054,292,647 | 3 / 4 |
| 2026-10-05 | $0.87 | $1,054,292,647 | 3 / 4 |
| 2026-10-06 | $0.87 | $1,054,292,647 | 3 / 4 |
| 2026-10-07 | $0.87 | $1,054,292,647 | 3 / 4 |
| 2026-10-08 | $0.87 | $1,054,292,647 | 3 / 4 |
| 2026-10-09 | $0.87 | $1,054,292,647 | 3 / 4 |
| 2026-10-10 | $0.87 | $1,054,292,647 | 3 / 4 |
| 2026-10-11 | $0.87 | $1,054,292,647 | 3 / 4 |
| 2026-10-12 | $0.87 | $1,054,292,647 | 3 / 4 |
| 2026-10-13 | $0.87 | $1,054,292,647 | 3 / 4 |
| 2026-10-14 | $0.87 | $1,054,292,647 | 3 / 4 |
| 2026-10-15 | $0.87 | $1,054,292,647 | 3 / 4 |
| 2026-10-16 | $0.87 | $1,054,292,647 | 3 / 4 |
| 2026-10-17 | $0.87 | $1,054,292,647 | 3 / 4 |
| 2026-10-18 | $0.87 | $1,054,292,647 | 3 / 4 |
| 2026-10-19 | $0.87 | $1,054,292,647 | 3 / 4 |
| 2026-10-20 | $0.87 | $1,054,292,647 | 3 / 4 |
| 2026-10-21 | $0.87 | $1,054,292,647 | 3 / 4 |
| 2026-10-22 | $0.87 | $1,054,292,647 | 3 / 4 |
| 2026-10-23 | $0.87 | $1,054,292,647 | 3 / 4 |
| 2026-10-24 | $0.87 | $1,054,292,647 | 3 / 4 |
| 2026-10-25 | $0.87 | $1,054,292,647 | 3 / 4 |
| 2026-10-26 | $0.87 | $1,054,292,647 | 3 / 4 |
| 2026-10-27 | $0.87 | $1,054,292,647 | 3 / 4 |
| 2026-10-28 | $0.87 | $1,054,292,647 | 3 / 4 |
| 2026-10-29 | $0.87 | $1,054,292,647 | 3 / 4 |
| 2026-10-30 | $0.87 | $1,054,292,647 | 3 / 4 |
| 2026-10-31 | $0.87 | $1,054,292,647 | 3 / 4 |
| 2026-11-01 | $0.87 | $1,054,292,647 | 3 / 4 |
| 2026-11-02 | $0.87 | $1,054,292,647 | 3 / 4 |
| 2026-11-03 | $0.87 | $1,054,292,647 | 3 / 4 |
| 2026-11-04 | $0.87 | $1,054,292,647 | 3 / 4 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 5 Buy / Strong Buy · 1 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.